3Ray A,Prefonlaine KE,Physical assocaition and functional antagonism between the p65 subunit of transcription factor NF-κ B and glucocorticoid receptor. Proc Natl Acad Sci USA, 1994,91:752～756.
4Barnes PJ. Beta-ardrenergic receptors and their regulation:state of the art. Am J kespir crit care med, 1995,152:838～ 860.
5Van de Slolpe A,Caldenhoven E,Raaijmakers JAM,et al. Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytes and bronchial epitheliai celltines. Am J Respir cell mol Biol,1993,8:340～347.
7Meduri GU. The role of the host defense response in the progression and outcome of ARDS:pathophysiologuc correlations and response to glucocorticoid treatment. Eur Rspir J, 1996,9: 2650～ 2670.
8Meduri UG, Kohler S, Headley E,et al. Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts poor outcome. Chest, 1995,108 : 1303～ 1314.
9Meduri GU,Headley S,Tolley E,et al. Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS. Chest,1995,108:1315～1325.
10Meduri GU,Tolley EA,Chinn A,et al. Procollagen types Ⅰ and Ⅲ aminoterminal propertide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med,1998,158:1432～1441.
